IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Anthem Bioscience IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in Bangalore and caters to Pharmaceutical sector. Citigroup Global Markets India , J.P. Morgan India , Jm Financial , Nomura Financial Advisory And Securities (India) are the merchant bankers of Anthem Bioscience IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 31st December 2024.
Anthem Bioscience IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
1,342.04 cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Citigroup Global
IPO by BRLM so far:
70
City:
Bangalore
IPO so far:
10
Revenue (annualised):
₹
1821.60
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 25.12x
Anthem Bioscience IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Citigroup Global Markets India Private Limited is the book-running lead manager of the Anthem Bioscience IPO. [●] is the Registrar for Anthem Bioscience IPO.
Anthem Bioscience IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Anthem Bioscience IPO, based in Bangalore, operates in the Pharmaceutical sector with a focus on . The company is launching its MainBoard Upcoming IPO on the BSE,NSE exchange, using the Book Building Issue method. Anthem Bioscience IPO size is ₹ [●] with fresh issue size of ₹ [●] and Offer for sale being ₹ Nil
The IPO allotment date for Anthem Bioscience IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Anthem Bioscience IPO allotment status on the registrars website, [●]. Anthem Bioscience IPO refund dates are [●].
Anthem Bioscience IPO is expected to be listed on [●].
The upper price band for the Anthem Bioscience IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Anthem Bioscience IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Anthem Bioscience IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Anthem Bioscience IPO is finalised.
The merchant banker for Anthem Bioscience IPO is Citigroup Global Markets India Private Limited , J.P. Morgan India Private Limited , Jm Financial Limited , Nomura Financial Advisory And Securities (India) Private Limited . Citigroup Global Markets India Private Limited , J.P. Morgan India Private Limited , Jm Financial Limited , Nomura Financial Advisory And Securities (India) Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Anthem Bioscience IPO RHP for further details.
The registrar for Anthem Bioscience IPO is [●]. Investors can go to [●] registrar website for IPO allotment status, refund processing, and other queries related to Anthem Bioscience IPO through their official website or helpline.
Anthem Bioscience IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 1,342.04 Cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Citigroup Global
IPO by BRLM so far:
70
City:
Bangalore
IPO so far:
10
Revenue (annualised):
₹ 1,726.70 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 25.12x
Anthem Bioscience IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Anthem Bioscience Financial Review Page
Merchant Banker(s) of Anthem Bioscience IPO: Citigroup Global Markets India Private Limited , J.P. Morgan India Private Limited , Jm Financial Limited , Nomura Financial Advisory And Securities (India) Private Limited
Anthem Bioscience IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Anthem Bioscience IPO listed at a listing price of against the offer price of .
The current market price of Anthem Bioscience is .
Why Us?
